Online ISSN: 2515-8260

Keywords : symptoms


Features Of Thrombophilia In Covid-19

Dadajanov Utkur Dadajanovich; Mamatkulova Feruza Xaydarovna; Ruziboeva Oyjamol Narzullaevna

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 5199-5205

from this article we see that why COVID-19 causes thrombosis, A thrombus is a mixture of platelets, erythrocytes and fibrin protein, which begin to accumulate on the wall of the damaged vessel. gradually it thickens and hardens, but in general it resembles a viscous substance, similar to jelly,it can be unambiguously stated that with this virus, from the very beginning, there is an activation of hemostasis, intravascular blood coagulation and thrombus formation in small-caliber vessels of vital organs. In this case, not only the lungs are damaged, but the blockade of microcirculation and its irreversible nature determine the outcome of the disease.

Covid - 19 Pandemic In China - A Review.

K Helen Reshma; A.Jothi Priya; V. Vishnu Priya

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 3033-3038

The COVID - 19 pandemic is also known as coronavirus pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak was first identified in Wuhan, China, in December 2019. The source is probably from bats and possibly via pangolins. The virus is primarily spread between people during close contact, most often via small droplets produced by coughing, sneezing and talking. Common symptoms include fever, cough, shortness of breath and loss of sense of smell. Complications include pneumonia and acute respiratory distress syndrome. The time from exposure to onset of symptoms is typically around 5 days and ranges from 2 to 14 days. Prevention is by washing hands frequently, cleaning the surfaces, wearing face masks, self isolation and social distancing.

CHALLENGES FACED BY CHINA ON COVID-19

Hiranya . S; A.Jothi Priya; V.Vishnu Priya; Lakshminarayanan Arivarasu

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 2230-2235

COVID-19 disease is caused by coronavirus, a dreadful virus which affected China on December 19 in the city of Wuhan .In humans , these viruses cause respiratory tract infections that can range from mild to death.Most people infected with this virus have mild to moderate respiratory illness. This dreadful disease is caused by Severe Acute Respiratory Syndrome.Older people and those with underlying medical problems like cardiovascular disease,diabetes,chronic respiratory disease, and cancer are more likely to develop serious illness.The spread of disease is rapid from one country to another.In most of the studies it is being told that the death rates are increasing due to coronavirus.There are no vaccines or antiviral drugs to prevent or treat coronavirus. To review the challenges faced by china on covid19. The literature review is planned using a database like pubmed from the years 2015-2020 to know about the challenges faced by China